Effect of remifentanil infusion on profile of tracheal extubation and emergence from anaesthasia

Effect of remifentanil infusion on profile of tracheal extubation and emergence from anaesthasia in discectomy surgry

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201309074005N9

Enrollment

Registered

2015-03-16

Start date

2013-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Relation of remifentanil infusion on profile of tracheal extubation and emergence from anaesthesia in discectomy surgry. Condition 2: Relation of remifentanil infusion on profile of tracheal extubation and emergence from anaesthesia in discectomy surgry. Complication of surgical and medical care

Interventions

Intervention 1: Intervention group: After induction and management of anesthesia with total intravenous anesthesia using propofol 100µg/kg /min and remifentanil 0.5µg/kg/ min, in the end of operation

Treatment - Drugs

Intervention group: After induction and management of anesthesia with total intravenous anesthesia using propofol 100µg/kg /min and remifentanil 0.5µg/kg/ min, in the end of operation, propofol will

Control group: After induction and management of anesthesia with total intravenous anesthesia using propofol 100µg/kg/min and remifentanil 0.5µg/kg/min, in the end of operation, both propofol and rem

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteri : discectomy surgeries with general anaesthesi , aged 20-60 years with ASA1-2 Exclusion criteri : history of hypertention; asthma; chronic obestructive pulmonary disease; dificult air way; risk factor of aspiration; recent air way infection and chronic cough

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Spo2, HR, Bp, nausea and vomiting. Timepoint: Every 5 min to 30 min after extubation. Method of measurement: Pulse oximetry, manometer, visual analog scale.;Nausea. Timepoint: Post extubation. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
BP. Timepoint: Extubation and post extubation. Method of measurement: Manometer.;Vomiting. Timepoint: Post extubation. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahmoud Eidi

Tabriz University of Medical Sciences

eidy@tbzmed.ac.ir+98 41 1334 1994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026